The Heterogeneity of Pulmonary Hypertension Nomenclature in Empiric Research Studies: Systematic Findings From Three Western European Countries

28 April 2025

Armella Santi, Veranyuy Ngah, Eric W. Robbins, Bradley A. Maron, Katarina Zeder

Abstract

This systematic literature review of three Western European Countries identified N = 48 different terms to describe pulmonary arterial pressure and N = 35 thresholds used to define pulmonary hypertension in published empiric research studies. There is an urgent need to standardize pulmonary artery pressure nomenclature and pulmonary hypertension definitions in clinical research reports.

Read the full research letter

Other materials on this topic

13 December 2025

The Burden of Prior Authorizations for Pediatric Pulmonary Hypertension Medications: A Quantitative Assessment

This study quantified prior authorization (PA)—insurance-required approval—burden for pediatric pulmonary hypertension (PH) at an accredited center. Among 53 patients, 72% of 283 prescriptions between 2021 and 2023 required PA, with non-FDA-approved medications showing highest volume.

Pulmonary Circulation

16 June 2025

Climate impact of drug development

Presented at PVRI's Drug Discovery & Development Symposium 2025, by Frances Varian, University of Sheffield

Members Only

8 February 2024

Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare databases

Pulmonary arterial hypertension (PAH) is a rare subgroup of pulmonary hypertension (PH). Claims and administrative databases can be particularly important for research in rare diseases; however, there is a lack of validated algorithms to identify PAH...